Abstract
Purpose
The purpose was to determine significant predictors of treatment failure of skin and
soft tissue infections (SSTI) in the inpatient and outpatient setting.
Methods
A retrospective chart review of patients treated between January 1, 2005 to July 1,
2016 with ICD-9 or ICD-10 code of cellulitis or abscess. The primary outcome was failure
defined as an additional prescription or subsequent hospital admission within 30 days
of treatment. Risk factors for failure were identified through multivariate logistic
regression.
Results
A total of 541 patients were included. Seventeen percent failed treatment. In the
outpatient group, 24% failed treatment compared to 9% for inpatients. Overweight/obesity
(body mass index (BMI) > 25 kg/m2) was identified in 80%, with 15% having a BMI >40 kg/m2. BMI, heart failure, and outpatient treatment were determined to be significant predictors
of failure. The unit odds ratio for failure with BMI was 1.04 (95% [Cl] = 1.01 to
1.1, p = 0.0042). Heart failure increased odds by 2.48 (95% [Cl] = 1.3 to 4.7, p = 0.0056). Outpatients were more likely to fail with an odds ratio of 3.36.
Conclusion
Patients with an elevated BMI and heart failure were found to have increased odds
of failure with treatment for SSTIs. However, inpatients had considerably less risk
of failure than outpatients. These risk factors are important to note when making
the decision whether to admit a patient who presents with SSTI in the emergency department.
Thoughtful strategies are needed with this at-risk population to prevent subsequent
admission.
Keywords
To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D; use, select 'Corporate R&D; Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Trends in US hospital admissions for skin and soft tissue infections.Emerg. Infect. Dis. 2009; 15: 1516-1518
- Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital.J. Emerg. Med. 2015; 48: 508-519
- The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study.Diagn. Microbiol. Infect. Dis. 2009; 64: 305-310
- Obesity and heart failure as predictors of failure in outpatient skin and soft tissue infections.Antimicrob. Agents Chemother. 2017; 61
- ED management of cellulitis: a review of five urban centers.Am. J. Emerg. Med. 2001; 19: 535-540
- Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study.J. Am. Board Fam. Med. 2013; 26: 508-517
- Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis.Acad. Emerg. Med. 2014; 21: 526-531
- Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.N. Engl. J. Med. 2015; 372: 1093-1103
- Treatment failure in emergency department patients with cellulitis.CJEM. 2005; 7: 228-234
- Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship.Clin. Infect. Dis. 2010; 51: 895-903
- Obesity and infection.Lancet Infect. Dis. 2006; 6: 438-446
- Antibacterial prescribing in primary care.J. Antimicrob. Chemother. 2007; 60: i43-i47
- The epidemic of obesity.J. Clin. Endocrinol. Metab. 2004; 89: 2522-2525
World Health Organization. Internet Obesity and overweight. 2015; http://www.who.int/mediacentre/factsheets/fs311/en/.
Centers for Medicaid and Medicare Services.gov. Internet Phase two: payment reform. 2017; https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-Office/InitiativetoReduceAvoidableHospitalizations/PhaseTwoPaymentReform.html
- Antimicrobial dosing considerations in obese adult patients.Pharmacotherapy. 2007; 27: 1081-1091
- Clinical pharmacokinetics in heart failure. An updated review.Clin. Pharmacokinet. 1988; 15: 94-113
- The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.J. Am. Coll. Cardiol. 2009; 54: 1747-1762
- Hospitalization of elderly diabetic patients: characteristics, reasons for admission, and gender differences.BMC Geriatr. 2016; 16: 160
- Association of type 2 diabetes with prolonged hospital stay and increased rate of readmission in patients with lower limb cellulitis.Intern. Med. J. 2017; 47: 82-88
- Risk factors for recurrent lower extremity cellulitis in a U.S. Veterans Medical Center population.Am J Med Sci. 2006; 332: 304-307
- Switch over from intravenous to oral therapy: a concise overview.J. Pharmacol. Pharmacother. 2014; 5: 83-87
- Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment and site of care.Can. J. Infect. Dis. Med. Microbiol. 2008; 19: 173-184
- Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.Clin. Infect. Dis. 2014; 59: e10-e52
Article Info
Publication History
Published online: April 23, 2018
Accepted:
April 19,
2018
Received in revised form:
April 19,
2018
Received:
March 7,
2018
Identification
Copyright
Published by Elsevier Inc.
